 The primary objective is to compare two catheter lock solutions, TaurolockTMHep100 and Heparin 100 IEml, on the occurence of CRBSI. The secondary objectives are to compare the two devices according to other efficacy parameters, time to infection, cost and resource utility, tolerability and safety. 